A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 31, 2025

Conditions
Knee Osteoarthritis (OA)
Interventions
DIETARY_SUPPLEMENT

Native CT-II® (undenatured type II collagen)

"Strength: 40 mg in 3 capsules~Dose Regimen:~3 yellow capsules containing MCC after breakfast with water 3 blue capsules containing 40 mg Native CT-II® \& MCC after dinner with water Route of administration: Oral"

DIETARY_SUPPLEMENT

Glucosamine HCL + Chondroitin Sulphate (G+C) [Comparator]

2700 mg (1500 mg G + 1200 mg C) 3 yellow capsules containing G+C orally after breakfast with water \& 3 blue capsules containing G+C after dinner with water

DIETARY_SUPPLEMENT

Placebo [Microcrystalline Cellulose (MCC)

2700 mg excipient 3 yellow capsules containing MCC orally after breakfast with water 3 blue capsules containing MCC after dinner with water.

Trial Locations (5)

400053

Proactive Othopedic Clinic, Mumbai

400067

Ayush Nursing Home, Mumbai

Diamond Orthopedic & Multispeciality Hospital, Mumbai

410206

Sparsh Superspeciality Hospital, Panvel

422009

Life Care Hospital, Nashik

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT06917287 - A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis | Biotech Hunter | Biotech Hunter